Systemic lupus erythematosus with disease onset at 65 and older;Lupus érythémateux disséminé survenant après 65 ans

Revue de Medecine Interne

Volumn 24, Issue 5, 2003, Pages 288-294

  Gaujard, S ^a   Broussolle, C ^b   Cathebras, P ^c   Dupond, J L ^d   Massot, C ^e   Ninet, J ^f   Perrot, H ^g   Durand, D Vital ^h   Rousset, H ^h  

^a HOSPICES CIVILS DE LYON   (France)

^b Service de Medecine Interne   (France)

^c HÔPITAL NORD   (France)

^d UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f EDOUARD HERRIOT HOSPITAL   (France)

^g Hopital de l'Antiquaille   (France)

^h CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Aged; Autoimmune diseases; Lupus erythematosus; Systemic

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL NUCLEUS ANTIGEN; DOUBLE STRANDED DNA; GLUCOCORTICOID;

AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; DISEASE COURSE; FEMALE; GERIATRIC DISORDER; HUMAN; MALE; ONSET AGE; PROGNOSIS; SEX RATIO; SURVIVAL RATE; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0038542155     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)00052-3     Document Type: Article

References (35)

1. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteritics associated with poorer outcomes. Arthritis Rheum 1995;38:274-83.
2. Costallat LT, Coimbra AM. Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease of onset. Clin Exp Rheumatol 1994;12:603-7.
3. Koh ET, Boey ML. Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol 1994;21: 1463-7.
4. Font J, Pallares L, Cervera R, Lopez-Soto A, Navarro M, Bosch X, et al. Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis 1991;50:702-5.
5. Janwityanujit S, Totemchokchyakarn K, Verasertniyom O, Vanichapuntu M, Vatanasuk M. Age-related differences on clinical and immunological manifestations of SLE. Asian Pac J Allergy Immunol 1995;13:145-9.
6. Pu SJ, Luo SF, Wu YJJ, Cheng HS, Ho HH. The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 2000;9:96-100.
7. Tan EM, Cohen AS, Fries JF, Masi AT, Mac Shane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
9. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine (Baltimore) 1993;72:113-24.
10. Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus, Computer analysis of 520 cases. JAMA 1964;190: 112-9.
11. Tze Kwan Ho C, Chiu Mok C, Sing Lau C, Sing Wong RW. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 1998;57:437-40.
12. Kammer GM, Mishra N. Systemic lupus erythematosus in the elderly. Rheum Dis Clin North Am 2000;26:475-92.
13. Baer AN, Pincus T. Occult systemic lupus erythematosus in elderly men. JAMA 1983;249:3350-2.
14. Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R. Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index. Lupus 1999;8: 462-5.
15. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990;33:37-48.
16. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus, Patient characteritics associated with poorer outcomes. Arthritis Rheum 1995;38:274-83.
17. Gallo V, Petrino R, Rabbia F, Quadri R. Lupus eritematoso sistemico in uomo anziano con interessamento epatico, iperpigmentazione cutanea e aumento dei markers tumorali. Minerva Med 1988;79:579-81.
18. Hutton CW, Maddison PJ. Systemic lupus erythematosus presenting as polymyalgia rheumatica in the elderly. Ann Rheum Dis 1986;45: 641-4.
19. Maragou M, Siotsiou F, Sfondouris H, Nicolia Z, Vayopoulos G, Dantis P. Late-onset SLE presenting as polymyalgia rheumatica. Clin Rheumatol 1989;8:91-7.
20. ACR ad hoc committee on neuropsychiatric lupus nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42:599-608.
21. Dennis MS, Byrne EJ, Hopkinson N, Bendall P. Neuropsychiatric systemic lupus erythematosus in elderly people: a case series. J Neurol Neurosurg Psychiatry 1992;55:1157-61.
22. Monastero R, Bettini P, Del Zotto E, Cottini E, Tincani A, Balestrieri G, et al. Prevalence and patterns of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. J Neurol Sci 2001;184:33-9.
23. Candore G, Di Lorenzo G, Mansueto P, Melluso M, Frada G, Li Vecchi M, et al. Prevalence of organ-specific and non organ-specific autoantibodies in healthy centenarians. Mech Ageing Dev 1997;94: 183-90.
24. Bell DA. SLE in the elderly, Is it really SLE or systemic Sjögren syndrome? J Rheumatol 1988;15:723-4.
25. Meier CR, Sturkenboom MC, Cohen AS, Jick H. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol 1998;25:1515-9.
26. Sanchez-Guerrero J, Liang MH, Karlson EW, Hunter DJ, Colditz GA. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 1995;122:430-3.
27. Nossent JC, Swaak AJ. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med 1991;80:605-12.
28. Ward MM, Studenski S. Age associated clinical manifestation of SLE: a multivariate regression analysis. J Rheumatol 1990;17:476-81.
29. Berthier S, Magy N, Gil H, Becker Schneider M, Vuitton DA, Dupond JL. Myélodysplasies et maladies systémiques, Une association non fortuite. Rev Med Interne 2001;22:428-32.
30. Talor E, Rose NR. Hypothesis: the aging paradox and autoimmune disease. Autoimmunity 1991;8:245-9.
31. Slater CA, Davis RB, Shmerling RH. Antinuclear antibody testing. A study of clinical utility. Arch Intern Med 1996;156:1421-5.
32. Ruffatti A, Calligaro A, Del Ross T, Bertoli MT, Doria A, Rossi L, et al. Anti-double-stranded DNA antibodies in the healthy elderly: prevalence and characteristics. J Clin Immunol 1990;10: 300-3.
33. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJE, Goudevenos J, Moutsopoulos HM. High prevalence of anti-cardiolipin and other auto-antibodies in a healthy elderly population. Clin Exp Immunol 1987;69:557-65.
34. Piette JC, Cacoub P. Antiphospholipid syndrome in the elderly: caution. Circulation 1998;97:2195-6.
35. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996;348:423-8.